Advertisement

Reply

Published:March 17, 2020DOI:https://doi.org/10.1016/j.ajog.2020.03.010
      We appreciate the additional considerations outlined by Premkumar et al
      • Premkumar A.
      • Cassimatis I.
      • Berhie S.H.
      A critical appraisal of “Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis”.
      and would like to respond to their thoughtful comments regarding our recent cost-effectiveness analysis on using a point-of-care HIV quantification test in pregnant women living with HIV without prenatal care.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Reference

        • Premkumar A.
        • Cassimatis I.
        • Berhie S.H.
        A critical appraisal of “Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis”.
        Am J Obstet Gynecol. 2020; (https://doi.org/10.1016/j.ajog.2020.03.011 [Epub ahead of print])
        • Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission
        Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States.
        (Available at:)

      Linked Article